Efficacy Study of Nabilone in the Treatment of Diabetic Peripheral Neuropathic Pain
NCT01035281
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Diabetic Neuropathies
Interventions
DRUG:
Nabilone, flexible dosing
Sponsor
University of Calgary